Download PDF
Dtsch Med Wochenschr 2014; 139(14): 690-692
DOI: 10.1055/s-0034-1369854
Hämatologie & Onkologie | Commentary
Hämatologie, Onkologie, Intensivmedizin
© Georg Thieme Verlag KG Stuttgart · New York

Intensivmedizinische Betreuung onkologischer Patienten

Intensive care in oncology
M. Kochanek
1   1Klinik I für Innere Medizin, Schwerpunkt Internistische Intensivmedizin, Klinikum der Universität Köln
,
C. Wendtner
2   2Klinik für Hämatologie, Onkologie, Immunologie, Palliativmedizin, Infektiologie und Tropenmedizin, Klinikum Schwabing, München
,
A. Shimabukuro-Vornhagen
1   1Klinik I für Innere Medizin, Schwerpunkt Internistische Intensivmedizin, Klinikum der Universität Köln
,
B. Böll
1   1Klinik I für Innere Medizin, Schwerpunkt Internistische Intensivmedizin, Klinikum der Universität Köln
,
M. von Bergwelt-Baildon
1   1Klinik I für Innere Medizin, Schwerpunkt Internistische Intensivmedizin, Klinikum der Universität Köln
› Author Affiliations
Further Information

Publication History

Publication Date:
12 March 2014 (online)

Also available at
    Permissions and Reprints

Schlüsselwörter

maligne Erkrankungen - Thrombose - Hyponatriämie - Sepsis

Keywords

malignant diseases - thrombosis - hyponatremia - sepsis
 

  • Literatur

  • 1 Ay C, Dunkler D, Marosi C et al. Prediction of venous thromboembolism in cancer patients. Blood 2010; 116: 5377-5382
    CrossrefPubMedGoogle Scholar
  • 2 Azoulay E, Mokart D, Pene F et al. Outcomes of critically ill patients with hematologic malignancies: prospective multicenter data from France and Belgium. J Clin Oncol 2013; 31: 2810-2818
    CrossrefPubMedGoogle Scholar
  • 3 Brunkhorst FM, Engel C, Bloos F et al. Intensive insulin therapy and pentastarch resuscitation in severe sepsis. N Engl J Med 2008; 358: 125-139
    CrossrefPubMedGoogle Scholar
  • 4 Castillo JJ, Vincent M, Justice E. Diagnosis and management of hyponatremia in cancer patients. Oncologist 2012; 17: 756-765
    CrossrefPubMedGoogle Scholar
  • 5 Dellinger RP, Levy MM, Rhodes A et al. Surviving Sepsis Campaign: International Guidelines for Management of Severe Sepsis and Septic Shock, 2012. Intensive Care Med 2013; 39: 165-228
    CrossrefPubMedGoogle Scholar
  • 6 Dellinger RP, Levy MM, Rhodes A et al. Surviving Sepsis Campaign: International Guidelines for Management of Severe Sepsis and Septic Shock: 2012. Crit Care Med 2013; 41: 580-637
    CrossrefPubMedGoogle Scholar
  • 7 Khorana AA, Kuderer NM, Culakova E et al. Development and validation of a predictive model for chemotherapy-associated thrombosis. Blood 2008; 111: 4902-4907
    CrossrefPubMedGoogle Scholar
  • 8 Myburgh JA, Finfer S et al. Hydroxyethyl starch or saline for fluid resuscitation in intensive care. N Engl J Med 2012; 367: 1901-1911
    CrossrefPubMedGoogle Scholar
  • 9 Perner A, Haase N et al. Hydroxyethyl starch 130/0.42 versus Ringer’s acetate in severe sepsis. N Engl J Med 2012; 367: 124-134
    CrossrefPubMedGoogle Scholar
  • 10 Petereit C, Zaba O, Teber I et al. A rapid and efficient way to manage hyponatremia in patients with SIADH and small cell lung cancer. BMC Pulm Med 2013; 13: 55
    CrossrefPubMedGoogle Scholar
  • 11 Schellongowski P. Der hämatologisch-onkologische Patient auf der Intensivstation. Med Klin Intensivmed Notfmed 2013; 108: 203-208
    CrossrefPubMedGoogle Scholar
  • 12 Zarychanski R, Abou-Setta AM, Turgeon AF et al. Association of hydroxyethyl starch administration with mortality and acute kidney injury in critically ill patients requiring volume resuscitation. JAMA 2013; 309: 678-688
    CrossrefPubMedGoogle Scholar